Savella Tablet, Film Coated
Product Images NDC 0456-1510

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Savella (NDC 0456-1510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Savella 01

Chemical structure of milnacipran hydrochloride, the active ingredient in Savella. The diagram shows the molecular framework including a cyclopropane ring and phenyl group, depicting the compound's arrangement with hydrochloride.*

FDA Label Image

Savella 02

A line chart depicting the percent of patients improved against percent improvement in pain from baseline. The chart includes three curves labeled Plcb, MLN 100mg, and MLN 200mg, with the x-axis showing percent improvement in pain and the y-axis showing percent of patients improved.*

FDA Label Image

Savella 03

A line graph depicting the percent of patients improved versus percent improvement in pain from baseline for Savella (milnacipran hydrochloride) at 100 mg and 200 mg doses compared to placebo. The graph uses different lines to represent placebo, 100 mg milnacipran, and 200 mg milnacipran groups.*

FDA Label Image

Savella 04

Savella 12.5 mg film-coated tablets label for oral use containing milnacipran hydrochloride. The label indicates a package of 60 tablets, manufactured by Allergan, Inc. It includes dosage information, storage instructions, a barcode, and the NDC number 0456-1512-60.*

FDA Label Image

Savella 05

Savella 12.5 mg tablets packaging label for film-coated oral tablets containing milnacipran HCl. The label includes storage instructions, quantity of 100 tablets per bottle, and manufacturer Allergan, Inc. The NDC number and branding appear clearly on the label.*

FDA Label Image

Savella 06

Savella 25 mg film-coated tablets packaging label by Allergan, Inc. The label shows the proprietary name Savella with the generic name milnacipran HCl underneath. The package contains 60 tablets with a strength of 25 mg each. The label includes instructions to dispense the accompanying medication guide and storage information, as well as a barcode and NDC 0456-1525-60.*

FDA Label Image

Savella 07

Savella 50 mg film-coated tablets packaging label displaying the product name, active ingredient milnacipran hydrochloride, and that the bottle contains 60 tablets. It includes dosing instructions to dispense with the Medication Guide, storage temperature guidelines, and cautions to keep out of reach of children. The labeler is Allergan, Inc. The NDC number 0456-1550-60 is shown along with a barcode and a copyright date of 2016.*

FDA Label Image

Savella 08

Savella 100 mg film-coated tablets label for oral use, containing milnacipran hydrochloride. The label indicates the package contains 60 tablets and is produced by Allergan, Inc. It includes storage instructions and a note to dispense an accompanying Medication Guide to each patient.*

FDA Label Image

Savella 09

Packaging label for Savella (milnacipran HCl) Tablets 4-week Titration Pack by Allergan, Inc. The carton includes a blister pack with five 12.5 mg tablets, eight 25 mg tablets, and forty-two 50 mg tablets. The label provides dosing instructions for weeks 1 to 4 and reminds users to follow the enclosed medication guide. Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.